The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre

BACKGROUND: Clinical practice guidelines and re-imbursement schedules vary in the recommended timing of FDG-PET/CT in the diagnostic evaluation of suspected or confirmed lung cancer. The aim was to estimate the probability of requiring more than one invasive test to complete diagnosis and staging in...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Anne, Norman, Richard, Piccolo, Francesco, Manners, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252249/
https://www.ncbi.nlm.nih.gov/pubmed/34210303
http://dx.doi.org/10.1186/s12890-021-01564-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252249/
https://www.ncbi.nlm.nih.gov/pubmed/34210303
http://dx.doi.org/10.1186/s12890-021-01564-w

Ejemplares similares